Your browser doesn't support javascript.
loading
A CD6-targeted antibody-drug conjugate as a potential therapy for T cell-mediated disorders.
Zhang, Lingjun; Luo, Liping; Chen, Jin Y; Singh, Rupesh; Baldwin, William M; Fox, David A; Lindner, Daniel J; Martin, Daniel F; Caspi, Rachel R; Lin, Feng.
Afiliación
  • Zhang L; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA.
  • Luo L; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA.
  • Chen JY; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA.
  • Singh R; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Baldwin WM; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA.
  • Fox DA; Division of Rheumatology and Clinical Autoimmunity Center of Excellence, University of Michigan, Ann Arbor, Michigan, USA.
  • Lindner DJ; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Martin DF; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Caspi RR; Laboratory of Immunology, National Eye Institute, NIH, Bethesda, Maryland, USA.
  • Lin F; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, Ohio, USA.
JCI Insight ; 8(23)2023 Dec 08.
Article en En | MEDLINE | ID: mdl-37917882

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Inmunoconjugados / Enfermedad Injerto contra Huésped Límite: Animals / Humans Idioma: En Revista: JCI Insight Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Inmunoconjugados / Enfermedad Injerto contra Huésped Límite: Animals / Humans Idioma: En Revista: JCI Insight Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos